Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Milrinone Versus Dobutamine in Critically Ill Patients
NCT03207165Phase 4Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Aug 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of milrinone, dobutamine in low cardiac output syndrome (LCOS), cardiogenic shock, acute coronary syndrome (ACS), pulmonary edema, sponsored by University of Ottawa Heart Institute. Started Aug 2017; status: completed.
02
Drugs
milrinonedobutamine
03
Conditions
low cardiac output syndrome (LCOS)cardiogenic shockacute coronary syndrome (ACS)pulmonary edema
Beyond the preview
Go deeper on NCT03207165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03207165.